Circulating carcinoembryonic antigen (CEA), a growth parameter in malignant disease

Area of Science:

• Oncology
• Biochemistry
• Medical Diagnostics

Background:

• Carcinoembryonic Antigen (CEA) is a biomarker often elevated in various cancers.
• Understanding the correlation between tumor growth and CEA levels is crucial for patient management.

Purpose of the Study:

• To investigate the relationship between tumor volume/mass and serum CEA concentration in experimental and clinical settings.
• To evaluate the utility of CEA kinetics in predicting survival and treatment response in colorectal cancer.

Main Methods:

• Experiments involving human adenocarcinoma xenografts in nude mice, measuring tumor volume/mass and serum CEA.
• Retrospective analysis of CEA time courses in 114 patients with recurrent colorectal cancer.
• Correlation of CEA doubling times with patient survival and treatment outcomes.

Main Results:

• A linear relationship was observed between log CEA and time in mice, correlating with tumor mass.
• Similar linear CEA log increases were found in 87% of colorectal cancer patients.
• Individual CEA doubling times correlated with survival in metastatic disease and could assess therapy effectiveness.

Conclusions:

• Serum CEA concentration is a reliable indicator of tumor burden in adenocarcinoma xenografts.
• CEA kinetics, specifically doubling time, offer a valuable prognostic and predictive tool for colorectal cancer management.
• Tumor necrosis may explain dissociation between CEA levels and tumor growth rate.